French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

